Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased Fiona D.M. van Schaik, Martijn G.H. van Oijen Clinical Gastroenterology and Hepatology Volume 9, Issue 5, Pages 449-450.e1 (May 2011) DOI: 10.1016/j.cgh.2011.01.021 Copyright © 2011 AGA Institute Terms and Conditions
Supplementary Figure 1 Hazard ratios (HR) and 95% confidence intervals (CI) for the development of non-melanoma skin cancer (NMSC) categorized in different durations of thiopurine use. Clinical Gastroenterology and Hepatology 2011 9, 449-450.e1DOI: (10.1016/j.cgh.2011.01.021) Copyright © 2011 AGA Institute Terms and Conditions